Zicong Yang

448 total citations
23 papers, 302 citations indexed

About

Zicong Yang is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Zicong Yang has authored 23 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in Zicong Yang's work include IL-33, ST2, and ILC Pathways (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Whipple's Disease and Interleukins (4 papers). Zicong Yang is often cited by papers focused on IL-33, ST2, and ILC Pathways (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Whipple's Disease and Interleukins (4 papers). Zicong Yang collaborates with scholars based in China, United States and Israel. Zicong Yang's co-authors include Yingzhong Lin, Ling Liu, Lei Shi, Qingwei Ji, Ying Shi, Tao Zeng, Yan Xue, Lei Wang, Menglong Wang and Jishou Zhang and has published in prestigious journals such as European Journal of Pharmacology, Medicine and Clinica Chimica Acta.

In The Last Decade

Zicong Yang

21 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zicong Yang China 12 118 79 76 44 42 23 302
Myoung Ju Koh South Korea 9 89 0.8× 78 1.0× 54 0.7× 88 2.0× 37 0.9× 14 412
Azita Rashidi Norway 5 126 1.1× 132 1.7× 55 0.7× 48 1.1× 16 0.4× 7 295
Isabelle Daissormont Netherlands 6 199 1.7× 89 1.1× 38 0.5× 57 1.3× 30 0.7× 8 349
А. В. Потехина Russia 10 108 0.9× 94 1.2× 143 1.9× 45 1.0× 21 0.5× 49 357
Chuandong Wei China 12 103 0.9× 71 0.9× 26 0.3× 64 1.5× 21 0.5× 17 310
Selin Gencer Germany 10 170 1.4× 132 1.7× 52 0.7× 71 1.6× 16 0.4× 14 375
Qingwei Ji China 11 157 1.3× 93 1.2× 71 0.9× 48 1.1× 13 0.3× 15 350
Bart Legein Germany 6 159 1.3× 103 1.3× 40 0.5× 62 1.4× 20 0.5× 8 337
Zhengde Lu China 9 187 1.6× 139 1.8× 61 0.8× 66 1.5× 11 0.3× 13 373
Xinbo Zhao China 11 71 0.6× 160 2.0× 121 1.6× 41 0.9× 15 0.4× 26 385

Countries citing papers authored by Zicong Yang

Since Specialization
Citations

This map shows the geographic impact of Zicong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zicong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zicong Yang more than expected).

Fields of papers citing papers by Zicong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zicong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zicong Yang. The network helps show where Zicong Yang may publish in the future.

Co-authorship network of co-authors of Zicong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zicong Yang. A scholar is included among the top collaborators of Zicong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zicong Yang. Zicong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zicong, et al.. (2024). Predicting Employee Attrition Using Machine Learning Approaches. 419–426.
3.
Li, Shicheng, et al.. (2023). In silico analysis and verification of critical genes related to vascular calcification in multiple diseases. Cell Biochemistry and Function. 41(8). 1242–1251. 5 indexed citations
4.
Yang, Zicong, Lei Shi, Ying Shi, et al.. (2022). Vaspin Alleviates Sepsis-Induced Cardiac Injury and Cardiac Inflammation by Inhibiting Kallikrein 7 in Mice. Mediators of Inflammation. 2022. 1–12. 5 indexed citations
5.
Zhang, Jianwei, Zicong Yang, Mengjie Wang, et al.. (2022). Secreted frizzled-related protein 4 exerts anti-atherosclerotic effects by reducing inflammation and oxidative stress. European Journal of Pharmacology. 923. 174901–174901. 15 indexed citations
6.
Zhang, Jianwei, Zicong Yang, Changxing Hu, et al.. (2021). Anti‐Interleukin‐16‐Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin‐Treated Mice. Mediators of Inflammation. 2021(1). 6611085–6611085. 11 indexed citations
7.
Zhang, Jianwei, Zicong Yang, Mengjie Wang, et al.. (2021). Anti‐Interleukin‐16 Neutralizing Antibody Treatment Alleviates Sepsis‐Induced Cardiac Injury and Dysfunction via the Nuclear Factor Erythroid‐2 Related Factor 2 Pathway in Mice. Oxidative Medicine and Cellular Longevity. 2021(1). 6616422–6616422. 11 indexed citations
9.
Yang, Zicong, et al.. (2021). Diagnosis and treatment of eosinophilic myocarditis. Journal of Translational Autoimmunity. 4. 100118–100118. 39 indexed citations
10.
Ye, Jing, Yuan Wang, Zhen Wang, et al.. (2020). The Expression of IL-12 Family Members in Patients with Hypertension and Its Association with the Occurrence of Carotid Atherosclerosis. Mediators of Inflammation. 2020. 1–10. 23 indexed citations
11.
Shi, Lei, Qingwei Ji, Ling Liu, et al.. (2020). IL‐22 produced by Th22 cells aggravates atherosclerosis development in ApoE −/− mice by enhancing DC‐induced Th17 cell proliferation. Journal of Cellular and Molecular Medicine. 24(5). 3064–3078. 22 indexed citations
13.
Ye, Jing, Yuan Wang, Zhen Wang, et al.. (2020). Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges. Frontiers in Pharmacology. 11. 129–129. 46 indexed citations
14.
Zeng, Tao, Yu Liu, Lei Shi, et al.. (2020). ADAMTS-5 Decreases in Aortas and Plasma From Aortic Dissection Patients and Alleviates Angiotensin II-Induced Smooth Muscle-Cell Apoptosis. Frontiers in Cardiovascular Medicine. 7. 136–136. 8 indexed citations
15.
Shi, Ying, Shu Zhang, Yan Xue, et al.. (2020). IL-35 polymorphisms and cognitive decline did not show any association in patients with coronary heart disease over a 2-year period. Medicine. 99(31). e21390–e21390. 3 indexed citations
16.
Yang, Zicong, Lei Shi, Tao Zeng, et al.. (2020). Circulating Sestrin Levels Are Increased in Hypertension Patients. Disease Markers. 2020. 1–8. 18 indexed citations
17.
Ye, Jing, Yuan Wang, Zhen Wang, et al.. (2020). Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice. Aging. 12(1). 193–203. 16 indexed citations
18.
Shi, Lei, Qingwei Ji, Ling Liu, et al.. (2019). IL-22 Produced by Th22 Cells Aggravates Atherosclerosis Development in ApoE-/- Mice by Enhancing DC-Induced Th17 Cell Proliferation. SSRN Electronic Journal. 1 indexed citations
19.
Yang, Zicong, Lei Shi, Yan Xue, et al.. (2019). Interleukin-32 increases in coronary arteries and plasma from patients with coronary artery disease. Clinica Chimica Acta. 497. 104–109. 18 indexed citations
20.
Zeng, Tao, Jun Yuan, Lei Shi, et al.. (2018). Thrombospondin 1 Is Increased in the Aorta and Plasma of Patients With Acute Aortic Dissection. Canadian Journal of Cardiology. 35(1). 42–50. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026